India on Friday recorded 34,403 new cases and 320 deaths, taking the cumulative caseload to 33,381,728 (339,056 active cases) and the death toll to 444,248.
Worldwide: over 227.84 million cases and over 4.68 million deaths.
Vaccination in India: 765,717,137 doses. Worldwide: Over 5.82 billion doses.
A new study by the Indian Council of Medical Research (ICMR) suggests that SARS-CoV-2 can infect a high proportion of pregnant women, and when symptomatic, a large proportion can develop moderate to severe illness. Is.
It also said that co-infection can be a major risk for pregnant women with COVID-19 in the Indian context.
the study
The experts analyzed data of 4,203 women with Covid-19 in Maharashtra for the study, of whom 3,865 were registered during their pregnancy and 338 during the postpartum period. The majority of women (3441, 82%) were aged 18–30 years, 92% were in the third trimester and the mean gestational age was 38 weeks.
According to the study, most (3669, 87.3%) pregnant and postpartum women did not have symptoms of COVID-19 and only 534 (12.7%) were symptomatic.
Conclusion
The study found that pregnant and postpartum women over the age of 30 had a “two times higher severity” of COVID-19 disease than women under the age of 30.
The most common complications were preterm delivery (528, 16.3%) and hypertensive disorders in pregnancy (328, 10.1%). A total of 158 (3.8%) pregnant and postpartum women required intensive care, of which 152 (96%) were due to COVID-19 related complications.
According to experts, higher case fatality rates (CFRs) were observed in Vidarbha (9/1155, 0.8%), Pune (9/853, 1.1%) and Marathwada (4/351, 1.1%) regions as compared to Mumbai metropolis. (11/1684, 0.7%), and Khandesh (1/160, 0.6%) regions. Co-morbidities of anemia, tuberculosis and diabetes mellitus were associated with maternal death.
In severe COVID-19 cases, the most common presenting symptoms were shortness of breath (34, 85%), dry cough (23, 57.5%) and fever (22, 55%). more information Here
The Uttarakhand High Court has lifted its ban on Char Dham Yatra, opening four Himalayan temples to fully vaccinated pilgrims carrying a COVID-negative report. Days before the annual pilgrimage began on July 1, the court had stayed the yatra on June 28, remarking that allowing the yatra would be “like inviting a disaster”.
What changed then? The state government argued in the court that the number of Kovid in the state has come down significantly and almost every temple in the country is now open for pilgrims. It added that institutions, including courts, have also reopened. The state said the yatra is the only source of livelihood for thousands of locals and should be allowed.
Earlier this week, local traders from Uttarkashi, Chamoli and Rudraprayag – the districts in which the four temples are located – appealed to the petitioners, who had filed the petition, which led to the ban on travel, to “livelihood and 25,000 To save people’s families.”
Sanctions: The government submitted that 800 devotees would be allowed to visit Kedarnath each day, while 600 pilgrims could go to Gangotri and 400 pilgrims to Yamunotri. The government had set a daily limit of 1,200 visitors to Badrinath, but the court capped the number to 1,000. The state also assured the court that only three people would be allowed in the sanctum sanctorum of a temple.
The government said the standard operating procedure for the yatra would be announced soon.
Earlier: In 2017, around 2.2 million devotees visited the Char Dham. In 2018, the number of tourists increased to 2.6 million and reached an all-time high of 3.2 million in 2019. In 2020, the pandemic delayed travel and only 300,000 pilgrims arrived in the state.
Follow the news important to you in real time. Join 3 crore news lovers.